AKT1 and diabetes mellitus: Specifically, the levels of p85 and p-Akt (Ser473) were both decreased in the hippocampus of DM (Figure 3(b)) when compared to the control group, while ZBPYR treatment could enhance p85 (Figure 3(b)) and Akt hyperphosphorylation (Figure 3(b)).